Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

PubWeight™: 2.86‹?› | Rank: Top 1%

🔗 View Article (PMC 1727835)

Published in Gut on March 01, 2000

Authors

E V Loftus1, M D Silverstein, W J Sandborn, W J Tremaine, W S Harmsen, A R Zinsmeister

Author Affiliations

1: Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Clinic, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Associated clinical trials:

Safety and Efficacy of AST-120 in the Treatment of Pouchitis | NCT00583076

Antibiotics for the Treatment of Ulcerative Colitis | NCT00355602

Articles citing this

Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut (2012) 2.65

A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol (2012) 2.63

Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol (2008) 2.41

Asthma and proinflammatory conditions: a population-based retrospective matched cohort study. Mayo Clin Proc (2012) 2.17

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut (2006) 1.97

The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77

Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach. Inflamm Bowel Dis (2013) 1.71

Measures of obesity and risk of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2015) 1.66

Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver (2010) 1.51

Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med (2012) 1.44

Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol (2016) 1.43

Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci (2009) 1.33

New pathophysiological insights and modern treatment of IBD. J Gastroenterol (2010) 1.31

Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology (2012) 1.27

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol (2004) 1.25

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut (2006) 1.25

Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? Postgrad Med J (2006) 1.23

Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing? World J Gastroenterol (2008) 1.21

Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut (2004) 1.20

Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ (2013) 1.18

Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol (2010) 1.13

Colon cancer stem cells: implications for prevention and therapy. Trends Mol Med (2008) 1.12

The role of mesalamine in the treatment of ulcerative colitis. Ther Clin Risk Manag (2007) 1.12

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol (2007) 1.12

Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci (2012) 1.10

Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland. World J Gastroenterol (2005) 1.05

Inflammatory bowel disease: genetic and epidemiologic considerations. World J Gastroenterol (2008) 1.03

Old-age inflammatory bowel disease onset: a different problem? World J Gastroenterol (2011) 1.00

Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut (2003) 0.98

Review of inflammatory bowel disease in China. ScientificWorldJournal (2013) 0.98

Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States. Clin Exp Gastroenterol (2010) 0.90

IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab. World J Gastroenterol (2005) 0.90

Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study. Gut (2003) 0.89

Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol (2008) 0.88

Peripheral neuropathy incidence in inflammatory bowel disease: a population-based study. Neurology (2013) 0.87

Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol (2014) 0.87

Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis (2013) 0.87

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis. Ther Clin Risk Manag (2007) 0.87

Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterol (2012) 0.86

Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women. Clin Gastroenterol Hepatol (2015) 0.86

Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts. Inflamm Bowel Dis (2015) 0.86

Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis (2014) 0.84

Crohn's disease in Tuzla region of Bosnia and Herzegovina: a 12-year study (1995-2006). Int J Colorectal Dis (2008) 0.84

Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis. Inflamm Bowel Dis (2013) 0.83

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. BMC Gastroenterol (2012) 0.82

Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study. Dig Dis Sci (2008) 0.82

Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease. Clin Exp Immunol (2012) 0.82

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes. Gastroenterol Hepatol (N Y) (2009) 0.81

Infliximab in ulcerative colitis. Biologics (2008) 0.80

Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm Bowel Dis (2014) 0.80

Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. J Negat Results Biomed (2012) 0.79

Inflammatory bowel disease and asthma: a population-based, case-control study. Inflamm Bowel Dis (2010) 0.79

Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010. Clin Gastroenterol Hepatol (2016) 0.78

What is the impact of age on adult patients with inflammatory bowel disease? Clujul Med (2013) 0.77

Elderly-onset IBD: a milder disease? Nat Rev Gastroenterol Hepatol (2013) 0.77

High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis (2015) 0.77

Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes. Dig Dis Sci (2016) 0.76

Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care. Am J Gastroenterol (2015) 0.76

Overcoming adherence issues in ulcerative colitis. Gastroenterol Hepatol (N Y) (2007) 0.76

The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature. Clin Exp Gastroenterol (2013) 0.76

Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.76

Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. World J Gastroenterol (2012) 0.76

Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway. BMC Public Health (2013) 0.76

Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.76

A new look at a mainstay ulcerative colitis therapy. Gastroenterol Hepatol (N Y) (2008) 0.75

Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study. Can J Gastroenterol Hepatol (2015) 0.75

Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases. Am J Case Rep (2017) 0.75

New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and Adherence. Gastroenterol Hepatol (N Y) (2010) 0.75

Pros and cons of medical management of ulcerative colitis. Clin Colon Rectal Surg (2010) 0.75

The incidence, prevalence, and survival of gastroparesis in olmsted county, Minnesota, 1996-2006 (gastroenterology 2009;136:1225-1233). J Neurogastroenterol Motil (2010) 0.75

Cutaneous manifestation of gastrointestinal disease. J Gastrointest Oncol (2016) 0.75

Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn's Disease and Ulcerative Colitis. Front Immunol (2016) 0.75

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clin Exp Gastroenterol (2017) 0.75

Gender disparities in ocular inflammatory disorders. Curr Eye Res (2014) 0.75

13-year mortality trends among hospitalized patients with inflammatory bowel disease. BMC Gastroenterol (2012) 0.75

Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis (2017) 0.75

Incidence of ulcerative colitis in the elderly. Dig Dis Sci (2006) 0.75

Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience. Dig Dis Sci (2017) 0.75

Articles cited by this

History of the Rochester Epidemiology Project. Mayo Clin Proc (1996) 21.72

The patient record in epidemiology. Sci Am (1981) 10.32

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut (1996) 3.94

Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol (1999) 3.34

Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology (1992) 2.86

The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51

Geographic variation of inflammatory bowel disease within the United States. Gastroenterology (1991) 2.33

Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology (1981) 1.99

Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut (1992) 1.96

Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82

Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81

Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol (1991) 1.73

Chronic ulcerative colitis: incidence and prevalence in a community. Gut (1987) 1.66

Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65

Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) Int J Epidemiol (1996) 1.65

Inflammatory bowel disease incidence: up, down or unchanged? Gut (1998) 1.62

Incidence of ulcerative colitis in Stockholm County 1955-1979. Scand J Gastroenterol (1985) 1.60

Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci (1984) 1.57

Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology (1996) 1.51

Inflammatory colon disease in Rochester, Minnesota, 1935-1964. Gastroenterology (1972) 1.45

Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol (1992) 1.32

An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology (1990) 1.29

Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut (1998) 1.26

Ulcerative colitis and indeterminate colitis in the city of Malmö, Sweden. A 25-year incidence study. Scand J Gastroenterol (1995) 1.20

Incidence of Crohn's disease in Olmsted County, Minnesota, 1935-1975. Am J Epidemiol (1980) 1.14

Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol (1996) 1.11

Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Int J Epidemiol (1997) 1.06

A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol (1996) 1.06

Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol (1988) 1.01

Prognosis of chronic ulcerative colitis in a community. Gut (1987) 1.01

Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide epidemiologic study. Scand J Gastroenterol (1998) 1.00

High incidence of inflammatory bowel disease in The Netherlands: results of a prospective study. The South Limburg IBD Study Group. Dis Colon Rectum (1998) 0.99

Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology (1991) 0.99

Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol (1994) 0.96

Has smoking changed the epidemiology of ulcerative colitis? Scand J Gastroenterol (1992) 0.94

Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol (1996) 0.90

Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med (1988) 0.88

Articles by these authors

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med (1987) 7.73

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90

A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60

Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis (1998) 3.96

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther (2002) 3.71

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60

A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43

Yield of laboratory tests for case-finding in the ambulatory general medical examination. Am J Med (1996) 3.42

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med (1997) 3.31

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 3.29

Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol (1999) 2.95

Hereditary angioedema: a broad review for clinicians. Arch Intern Med (2001) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med (1982) 2.58

Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57

A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery (2001) 2.57

Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56

Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc (1995) 2.55

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA (1993) 2.42

The diagnosis of neoplasia in patients with asymptomatic microscopic hematuria: a decision analysis. J Urol (1988) 2.41

Patient-physician agreement on reasons for ambulatory general medical examinations. Mayo Clin Proc (1998) 2.35

Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35

Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33

The rational clinical examination. Does this dizzy patient have a serious form of vertigo? JAMA (1994) 2.30

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc (1994) 2.23

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther (2010) 2.20

Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19

CT colonography without cathartic preparation: feasibility study. Radiology (2001) 2.19

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther (2014) 2.18

Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17

Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17

Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction. Gastroenterology (1999) 2.14

Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13

Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12

Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09

Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08

Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Mycophenolate mofetil for Crohn's disease? Lancet (1999) 2.03

Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01

Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99

Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther (2013) 1.99

Patient-physician agreement about medical diagnoses and cardiovascular risk factors in the ambulatory general medical examination. Mayo Clin Proc (1996) 1.97

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther (2005) 1.96

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94

Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94

Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92

Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88

The epidemiology of venous thromboembolism in the community. Thromb Haemost (2001) 1.86

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84

MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology (1990) 1.84

Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82

Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci (1995) 1.81